Untreated Adult Acute Myeloid Leukemia Terminated Phase 2 Trials for Trametinib (DB08911)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01907815Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid LeukemiaTreatment